Cancer Management and Research · 2020 · 32 citations · 10 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer Cell SignalingCancer ProgressionColorectal CancerEpithelial-mesenchymal TransitionMetastatic Signaling PathwaysSignal Transduction In CancerEpithelial-mesenchymal TransformationEpithelial-mesenchymal Transition In CancerLuciferase Reporter AssaysLuciferase ReportersMicrorna In CancerMicrorna Regulation In CancerMicrorna Regulation Of EmtWestern Blotting
PURPOSE: This study aimed to investigate the effects of microRNA (miR)-22 on biological behaviors of colon cancer cells and to explore the relationship between miR-22 and NLRP3. MATERIALS AND METHODS: First, human colon cancer HCT116 cells were transfected with a miR-22 mimic, miR-22 inhibitor, control mimic, and control inhibitor, respectively. CCK8, colony formation, and transwell assays were performed to observe cell proliferation, migration, and invasion. Western blotting was used to analyze the expression of recombinant NLRP3 (NLR family, pyrin domain-containing protein 3) and epithelial-mesenchymal transformation (EMT)-related proteins. The target relationship between miR-22 and NLRP3 was verified by double luciferase report. Second, an NLRP3 inhibitor and NLRP3 mimic were transfected into HCT116 cells, and the biological behaviors and EMT-related proteins were again observed. Finally, a nude mouse xenograft model was constructed to verify the above results. RESULTS: In vitro, compared with the control group, administration of the miR-22 mimic significantly decreased proliferation, migration, and invasion of HCT116 cells, whereas the miR-22 inhibitor markedly increased their proliferation and invasion (p<0.05). Levels of NLRP3, interleukin-1β (IL-1β), matrix metalloproteinase-9 (MMP-9), MMP-2, N-cadherin, and vimentin were significantly reduced after miR-22 mimic transfection (p<0.05). Furthermore, silencing of NLRP3, a downstream gene of miR-22 in HCT116 cells, suppressed proliferation, migration, and invasion of HCT116 cells. However, overexpression of NLRP3 weakened the effects of the miR-22 mimic. In vivo, overexpression of miR-22 slowed the growth rate of tumors and reduced Ki-67 expression in tumor tissues compared with the model group (p<0.05). In tumor tissues, overexpression of miR-22 also decreased expression of NLRP3, IL-1β, MMP-9, MMP-2, N-cadherin, and vimentin compared with the model group (p<0.05). Overexpression of NLRP3 weakened the role of miR-22 overexpression in vivo. CONCLUSION: miR-22 suppresses cell proliferation, migration, and invasion in colorectal cancer by targeting NLRP3.
10
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer · 2010 · 21.4K citations
Genetic alterations in colorectal cancer.
Tannaz Armaghany, Jon D. Wilson, Quyen Chu et al. · PubMed · 2012 · 379 citations
MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis
S Li, Xiaohong Liang, Lin Ma et al. · Oncogene · 2017 · 164 citations
The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer
Yanqing Liu, Xiaorui Chen, Xi Chen et al. · Molecular Cancer · 2018 · 136 citations · Full text